The cognition-enhancer nefiracetam is protective in BDNF-independent neuronal cell death under the serum-free condition

Neurochem Int. 2002 Feb;40(2):139-43. doi: 10.1016/s0197-0186(01)00080-8.

Abstract

Cortical cells from embryonic mice (E17) showed a rapid cell-death under the serum-free condition. The addition of nefiracetam at 0.1-10 microM increased the survival activity, while aniracetam at the same concentrations did not. The cell death was characterized to be apoptotic, since dead cells showed nuclear condensation, fragmentation, and TUNEL-positive staining. The nefiracetam-induced anti-apoptotic activity was completely blocked by 1 microM nifedipine or omega-conotoxin GVIA, and partially by 1 microM verapamil. These results suggest that the reported anti-amnesic action of nefiracetam in ischemic animals may be partly attributed to the neuroprotective action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Brain-Derived Neurotrophic Factor / pharmacology*
  • Cell Death / drug effects*
  • Cell Survival / drug effects*
  • Cells, Cultured
  • Cerebral Cortex / cytology*
  • Cerebral Cortex / embryology
  • Cognition / drug effects
  • Cognition / physiology
  • Culture Media, Serum-Free
  • Embryo, Mammalian
  • In Situ Nick-End Labeling
  • Mice
  • Mice, Inbred Strains
  • Neurons / cytology*
  • Neurons / drug effects
  • Nootropic Agents / pharmacology*
  • Pyrrolidinones / pharmacology*
  • Verapamil / pharmacology
  • omega-Conotoxin GVIA / pharmacology
  • omega-Conotoxins / pharmacology

Substances

  • Brain-Derived Neurotrophic Factor
  • Culture Media, Serum-Free
  • Nootropic Agents
  • Pyrrolidinones
  • omega-Conotoxins
  • nefiracetam
  • omega-Conotoxin GVIA
  • Verapamil